Compare · BON vs TLRY
BON vs TLRY
Side-by-side comparison of Bon Natural Life Limited (BON) and Tilray Brands Inc. (TLRY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BON and TLRY operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- TLRY is the larger of the two at $2.44B, about 90.9x BON ($26.9M).
- Over the past year, BON is down 23.6% and TLRY is up 41.0% - TLRY leads by 64.6 points.
- TLRY has been more active in the news (12 items in the past 4 weeks vs 7 for BON).
- TLRY has more recent analyst coverage (14 ratings vs 0 for BON).
- Company
- Bon Natural Life Limited
- Tilray Brands Inc.
- Price
- $1.26+0.00%
- $6.74-2.67%
- Market cap
- $26.9M
- $2.44B
- 1M return
- -9.03%
- -3.23%
- 1Y return
- -23.64%
- +40.96%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2018
- News (4w)
- 7
- 12
- Recent ratings
- 0
- 14
Tilray Brands Inc.
Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.
Latest BON
- SEC Form 3 filed by new insider Chen Jing Veronica
- SEC Form 3 filed by new insider Hu Yongwei
- SEC Form 3 filed by new insider Xue Yingchun
- SEC Form 3 filed by new insider Ma Xin
- SEC Form 3 filed by new insider Wenjuan Chen
- SEC Form 3 filed by new insider Liu Jing
- SEC Form 3 filed by new insider Gao Jianjun
- BON Unveils Strategic Partnership with Tigerbone Group to Launch New Natural Health Initiatives
- SEC Form 6-K filed by Bon Natural Life Limited
- BON Announces Breakthrough Development of Apple Bio-Electronic Mask: Clinical Data Exceeds Expectations, Targeting $100B+ Medical Aesthetics Market
Latest TLRY
- Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling
- BrewDog USA Doubles Down on Headliners and Ignites Next Wave of Innovation for Spring and Summer
- SEC Form 4 filed by Hopkinson David G.
- Tilray Brands Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 424B7 filed by Tilray Brands Inc.
- Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care
- SEC Form 424B5 filed by Tilray Brands Inc.
- Tilray Brands Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Tilray Brands Accelerates Next Phase of Global Growth and Market Leadership
- Tilray Brands Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities